STM Journals Peer-reviewed research from Consortium e-Learning Network

Research and Reviews : A Journal of Life Sciences Article Open Access

A Comprehensive Review on COVID-19 Evolution and Development

  1. Sarepalli Sai Sathwik
  2. Tulasi Nikshitha
  3. Thipurani Murali Krishna y, Chaitanya Institute of Science and Technology (Chaitanya Deemed University)

Abstract

The emerging pandemic causing flu-like symptoms in patients is caused by the novel Coronavirus that was previously called 2019-nCoV. The mutated gene of SARS-CoV was transformed to SARS-CoV-2 in animals and further transmitted to humans in the month of December 2019 in Wuhan city of China. Eventually, the novel coronavirus spread all around the globe as a highly contagious disease. COVID-19 (the illness caused by coronavirus) has affected 213 countries and territories around the world. There are about 18,852,205 new positive cases, 707,451 casualties, 12,032,508 recoveries till date that is, 05th August 2020. This virus resulted in Acute Respiratory Distress Syndrome (ARDS) and multi-organ dysfunction. Human transmissions are caused due to inhaling or by contact with viral droplets. The infected patient seems to show an incubation period of 2–14 days. Due to this ominous situation, several countries got shut down to contain the spread of novel coronavirus. This review article includes the etiology, epidemiology, detection and diagnosis, histopathology, pathophysiology of novel coronavirus. To control the virus, many drugs are in use. Short-term testing kits have been discovered by many countries using the Reverse transcriptase-polymerase chain reaction (RT-PCR) technique. Vaccines from numerous research laboratories are at the stage of human trails. This review article can be preferred for further investigation on coronavirus.

Keywords

References (36)

  1. Chan JFW, Kok KH, Zhu Z, Chu H, To KKW, Yuan S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes & Infections. 2020;9(1):221-236. doi:10.1080/22221751.2020.1719902
  2. K. Ramanathan et al., “Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- research that is available on the COVID-19 resource centre - including this for unrestricted research re-use a,” no. January, pp. 19–21, 202A Comprehensive Review on COVID-19 Evolution and Development0.
  3. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). Treasure Island (FL): StatPearls Publishing; 2020.
  4. Chan JFW, To KKW, Tse H, Jin DY, Yuen KY. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends in Microbiology. 2013;21(10):544-555. doi:10.1016/j.tim.2013.05.005
  5. Zhang T, Wu Q, Zhang Z. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak. Current Biology. 2020;30(7):1346-1351.e2. doi:10.1016/j.cub.2020.03.022
  6. World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. Geneva: WHO; 2020.
  7. Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al. Coronavirus Disease 2019 (COVID-19): A Perspective from China. Radiology. 2020;296(2):E15-E25. doi:10.1148/radiol.2020200490
  8. Ramphul K, Mejias SG. Coronavirus Disease: A Review of a New Threat to Public Health. Cureus. 2020. doi:10.7759/cureus.7276
  9. Yu H, Wang XC, Li J, Qian X, Yu XF, Sun Z, Chen JF, Kao QJ, Wang HQ, Pan JC. Genomic analysis of a 2019-nCoV strain in the first COVID-19 patient found in Hangzhou, Zhejiang, China. Zhonghua Yu Fang Yi Xue Za Zhi. 2020; 54(5): 486–490p. doi:10.3760/cma.j.cn112150-20200217-00128.
  10. Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, et al. Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature. 2020; 582: 289–293p. doi:10.1038/s41586-020-2223-y.
  11. Coronavirus Update (Live): 3,744,765 Cases and 258,884 Deaths from COVID-19 Virus Pandemic. Worldometer. Available from: https://www.worldometers.info/ coronavirus/ (accessed on 2020 May 06).
  12. Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer. J Thorac Oncol. 2020; 15(5): 700–704p.
  13. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine. 2020;382(18):1708-1720. doi:10.1056/nejmoa2002032
  14. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506. doi:10.1016/s0140-6736(20)30183-5
  15. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020;296(2):E32-E40. doi:10.1148/radiol.2020200642
  16. Wang L, Wang Y, Ye D, Liu Q. A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence. Int J Antimicrob Agents. 2020; 55(6): 105948. doi:10.1016/j.ijantimicag.2020.105948.
  17. Broughton JP, Deng X, Yu G, Fasching CL, Singh J, Streithorst J, et al. Rapid Detection of 2019 Novel Coronavirus SARS-CoV-2 Using a CRISPR-based DETECTR Lateral Flow Assay. 2020. doi:10.1101/2020.03.06.20032334
  18. Zhang F, Abudayyeh OO, Gootenberg JS, Sciences C, Mathers L. A protocol for detection of COVID-19 using CRISPR diagnostics. Bioarchive. 2020.
  19. Khedkar PH, Patzak A. SARS‐CoV‐2: What do we know so far? Acta Physiologica. 2020;229(2). doi:10.1111/apha.13470
  20. Mathew JC. First Made-in-India COVID-19 test kit by Mylab gets commercial approval. Business Today; 2020.
  21. Abbott. Abbot launches molecular point-of-care test to detect novel coronavirus in as little as five minutes. Abbot .Mediaroom Com; 2020.
  22. Zhang J, Liu J, Li N, Liu Y, Ye R, Qin X, Zheng R. Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing. medRxiv. 2020. doi: 10.1101/ 2020.03.04.20030916.
  23. Wang J, Tang K, Feng K, Lv W. High Temperature and High Humidity Reduce the Transmission of COVID-19. SSRN Electron J. 2020. doi: 10.2139/ ssrn.3551767.
  24. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-513. doi:10.1016/s0140-6736(20)30211-7
  25. Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). The Indian Journal of Pediatrics. 2020;87(4):281-286. doi:10.1007/s12098-020-03263-6
  26. Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. BioScience Trends. 2020;14(1):72-73. doi:10.5582/bst.2020.01047
  27. Smit C, Peeters MYM, van den Anker JN, Knibbe CAJ. Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties. Clinical Pharmacokinetics. 2020;59(6):659-669. doi:10.1007/s40262-020-00891-1
  28. Huang J, Song W, Huang H, Sun Q. Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19. Journal of Clinical Medicine. 2020;9(4):1131. doi:10.3390/jcm9041131
  29. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research. 2020;30(3):269-271. doi:10.1038/s41422-020-0282-0
  30. Fu B, Xu X, Wei H. Why tocilizumab could be an effective treatment for severe COVID-19? Journal of Translational Medicine. 2020;18(1). doi:10.1186/s12967-020-02339-3
  31. Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S. Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection. The Journal of Immunology. 2017;198(10):4046-4053. doi:10.4049/jimmunol.1601896
  32. Robinson DP, Hall OJ, Nilles TL, Bream JH, Klein SL. 17β-Estradiol Protects Females against Influenza by Recruiting Neutrophils and Increasing Virus-Specific CD8 T Cell Responses in the Lungs. Journal of Virology. 2014;88(9):4711-4720. doi:10.1128/jvi.02081-13
  33. Whitfield J, Littlewood T, Soucek L. Tamoxifen Administration to Mice. Cold Spring Harbor Protocols. 2015;2015(3):pdb.prot077966. doi:10.1101/pdb.prot077966
  34. Thanh Le T, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M, et al. The COVID-19 vaccine development landscape. Nature Reviews Drug Discovery. 2020;19(5):305-306. doi:10.1038/d41573-020-00073-5
  35. Smith TRF, Patel A, Ramos S, Elwood D, Zhu X, Yan J, et al. Rapid development of a synthetic DNA vaccine for COVID-19. 2020. doi:10.21203/rs.3.rs-16261/v1
  36. Center for Health Security. Serology testing for COVID-19. USA: Johns Hopkins; 2020. doi:10.1101/2020.01.28.923011.
Support